Skip to main content

Table 1 HLA-A, -B and -Cw allele frequencies in ME and TU

From: Associations between HLA Class I alleles and the prevalence of nasopharyngeal carcinoma (NPC) among Tunisians

HLA-A allele (ME n = 73; TU n = 147)

 

ME

TU

 

ME

TU

 

ME

TU

A*010101

0.137

0.088

A*110101

0.048

0.030

A*3301

0.055

0.031

A*0102

0

0.003

A*2301

0.082

0.078

A*3303

0

0.01

A*0103

0

0.007

A*240201

0.062

0.037

A*33new*

0

0.003

A*020101

0.178

0.173

A*250101

0.007

0.007

A*3402

0.021

0.01

A*0202

0

0.034

A*2601

0.007

0.031

A*3601

0

0.003

A*0205

0

0.024

A*2902

0.041

0.061

A*6601

0.021

0.02

A*0212

0

0.003

A*3001

0.014

0.031

A*680101

0.021

0.031

A*0285

0

0.003

A*3002

0.089

0.044

A*680102

0.021

0.014

A*02new*

0

0.003

A*3004

0.007

0.003

A*680201

0.048

0.054

A*030101

0.034

0.068

A*3010

0

0.003

A*7401

0.014

0.003

A*030103

0

0.003

A*310102

0.021

0.024

A*8001

0

0.007

A*0302

0.041

0.017

A*3201

0.034

0.034

   

HLA-B allele (ME n = 69; TU n = 148)

        
 

ME

TU

 

ME

TU

 

ME

TU

B*070201

0.022

0.041

B*3508

0

0.014

B*4901

0.051

0.027

B*0705,06

0.007

0.003

B*3701

0.007

0.007

B*5001

0.073

0.139

B*0801**

0.087

0.064

B*3801

0.014

0.020

B*5002

0.043

0.014

B*1302°°

0

0.017

B*390602

0

0.003

B*510101,02

0.043

0.054

B*1401

0.014

0.010

B*3910

0.007

0.007

B*5108

0

0.003

B*1402

0.036

0.054

B*3920

0

0.003

B*520101,02

0.007

0.024

B*1403

0

0.010

B*4001

0

0.010

B*5301^^

0.014

0.024

B*150101

0

0.014

B*4002

0.007

0.003

B*5303

0

0.003

B*1503

0.014

0.017

B*4101

0

0.017

B*53new*

0

0.003

B*1510

0

0.004

B*4102

0.065

0.020

B*5501

0

0.003

B*1516

0

0.017

B*4201

0

0.017

B*570101

0.014

0.003

B*151701

0

0.007

B*4202

0.007

0.007

B*5702

0

0.003

B*180101

0.051

0.023

B*4402

0.094

0.047

B*570302

0.007

0

B*2702

0.007

0.007

B*440301

0.116

0.071

B*5801

0.014

0.027

B*2703

0.007

0

B*440302

0.007

0

B*5802

0.007

0.003

B*2705,13^

0.021

0.010

B*4405

0

0.003

B*7301

0

0.007

B*350101,42

0.043

0.027

B*4427

0

0.007

B*7801

0.014

0

B*3502

0.007

0.017

B*4501

0.043

0.047

   

B*3503

0.014

0.014

B*470101

0.007

0.003

   

HLA-Cw allele (ME n = 63; TU n = 147)

        
 

ME

TU

 

ME

TU

 

ME

TU

Cw*0102

0

0.007

Cw*0602

0.183

0.218

Cw*140201

0.008

0.027

Cw*020202***

0.095

0.054

Cw*0701,06°

0.183

0.129

Cw*150201

0.016

0.034

Cw*0210

0.016

0.017

Cw*070201

0.032

0.054

Cw*150501,02

0.016

0.014

Cw*0302

0

0.010

Cw*0704,0711

0.016

0.010

Cw*1601

0.032

0.044

Cw*030301

0

0.003

Cw*0802

0.056

0.058

Cw*1602

0.016

0.007

Cw*030401, 02°°°

0

0.014

Cw*120201,02

0.008

0.024

Cw*160401

0

0.003

Cw*040101

0.159

0.126

Cw*120301

0.008

0.044

Cw*1701,02,03^^^

0.071

0.051

Cw*0501,03

0.087

0.048

Cw*12new*

0

0.003

   
  1. Alleles having a frequency > 5% are in bold. °Including Cw*070101,02; **Two samples in this group were assigned as B*080101; °°One sample in this group was assigned as B*130201; ^Two samples in this group were assigned as B*270502 (1ME, 1TU); ^^Two samples in this group were assigned as B*530101; ***One sample in this group was assigned as Cw*0202; °°°One sample in this group was assigned as Cw*0304; ^^^Cw*1703, af = 0.063 in ME.
  2. Not discriminated alleles due to polymorphisms outside the assayed exons are listed separated by ",". Nomenclature was updated until the sixth digit; seventh and eighth digits were not included in the table. In case of ambiguous allele combinations, the most frequent allele combination was included in the analysis.
  3. No statistically significant differences were identified in any comparison between the Tunisian and Moroccan cases.